换一批
换一批Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
第一作者：
Zong-Yang,Li
第一单位：
Brain Center, Department of Neurosurgery, Shenzhen Key Laboratory of Neurosurgery, Shenzhen Second People's Hospital, The Clinical College of Anhui Medical University, Shenzhen University 1st Affiliated Hospital, 3002# Sungang Road, Futian district, Shenzhen, 518035, China.
作者：
主题词
乙酰化作用(Acetylation);主动转运, 细胞核(Active Transport, Cell Nucleus);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);细胞凋亡(Apoptosis);苯甲酰胺类(Benzamides);细胞周期蛋白质类(Cell Cycle Proteins);细胞系, 肿瘤(Cell Line, Tumor);细胞核(Cell Nucleus);中枢神经系统肿瘤(Central Nervous System Neoplasms);达卡巴嗪(Dacarbazine);抗药性, 肿瘤(Drug Resistance, Neoplasm);药物协同作用(Drug Synergism);胶质母细胞瘤(Glioblastoma);组蛋白脱乙酰基酶抑制剂(Histone Deacetylase Inhibitors);同源盒结构域蛋白质类(Homeodomain Proteins);人类(Humans);NF-κB(NF-kappa B);信号传导(Signal Transduction);转录因子RelA(Transcription Factor RelA);转录, 遗传(Transcription, Genetic);转录激活(Transcriptional Activation);肿瘤抑制蛋白质类(Tumor Suppressor Proteins)
DOI
10.1007/s11064-016-2043-5
PMID
27632183
发布时间
2024-09-06
- 浏览0
Neurochemical research
3192-3205页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
